Issue Date: August 10, 2009
Stephen Fesik has joined Vanderbilt University Medical Center as professor of biochemistry. He will lead the cancer drug discovery initiatives of the Vanderbilt Institute of Chemical Biology and the Vanderbilt-Ingram Cancer Center. Fesik had been a divisional vice president of cancer research at Abbott Laboratories, building a pipeline of drug candidates showing promising anticancer activity.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society